Gesynta Pharma has completed recruitment for its Phase 2 trial [...]

AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Nearly half of surveyed patient groups say they engage with [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

NICE has recommended maralixibat for cholestatic pruritus caused by Alagille [...]

Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]

The FDA has cleared two devices from E2 for pulmonary [...]

A peer-reviewed study has found a significant correlation between Olink [...]

BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]